Found: 17
Select item for more details and to access through your institution.
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 5, p. 340, doi. 10.1093/nop/npy039
- By:
- Publication type:
- Article
Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gastric Acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 1, p. 33, doi. 10.1016/j.cllc.2014.07.005
- By:
- Publication type:
- Article
Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 2, p. 155, doi. 10.1007/s10637-006-9002-y
- By:
- Publication type:
- Article
Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 569, doi. 10.1007/s10637-005-1157-4
- By:
- Publication type:
- Article
Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 5, p. 1513, doi. 10.1007/s10067-019-04451-2
- By:
- Publication type:
- Article
Immune checkpoint inhibitor-induced granulomatosis with polyangiitis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 2, p. 456, doi. 10.1159/000500856
- By:
- Publication type:
- Article
Optimizing Entry into Canadian Cancer Care Systems.
- Published in:
- International Journal of Integrated Care (IJIC), 2022, v. 22, p. 1, doi. 10.5334/ijic.ICIC21252
- By:
- Publication type:
- Article
Management of Malignant Melanoma: Best Practices.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. 2, p. 55, doi. 10.2310/7750.2008.08029
- By:
- Publication type:
- Article
Anti‐PD1‐Induced Immune‐Related Adverse Events and Survival Outcomes in Advanced Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 438, doi. 10.1634/theoncologist.2019-0674
- By:
- Publication type:
- Article
Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2020, v. 11, n. 3, p. 748, doi. 10.1002/jcsm.12538
- By:
- Publication type:
- Article
Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2019, v. 10, n. 5, p. 1070, doi. 10.1002/jcsm.12451
- By:
- Publication type:
- Article